Trials / Conditions / Mucinous Breast Cancer Stage II
Mucinous Breast Cancer Stage II
4 registered clinical trials studyying Mucinous Breast Cancer Stage II.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Denosumab as an add-on Neoadjuvant Treatment (GeparX) NCT02682693 | GBG Forschungs GmbH | Phase 2 |
| Completed | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treat NCT02125344 | GBG Forschungs GmbH | Phase 3 |
| Completed | Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast NCT01583426 | GBG Forschungs GmbH | Phase 3 |
| Completed | Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer NCT01426880 | GBG Forschungs GmbH | Phase 2 / Phase 3 |